Early sepsis diagnosis by microfluid chip detection of CD64 biomarkers in patient blood samples
Polat G, Ugan R, Cadirci E, et al. Sepsis and septic shock: current treatment strategies and new approaches. The Eurasian J Medicine 2017; 49: 53-58.
Mat-Nor M, Ralib A, Abdulah N, et al. The diagnostic ability of procalcitonin and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. J Critical Care 2016; 33: 245-251.
Seymour C, Liu V, Iwashyna T, et al. Assessment of clinical criteria for sepsis for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). J American Medical Association 2016; 315(8): 762-774.
Gámez-Díaz L, Enriquez L, Matute J, et al. Diagnostic Accuracy of HMGB-1, s-TREM-1, and CD64 as markers of sepsis in patients recently admitted to the emergency Department. Academic Emergency Medicine 2011; 18(8): 807-815.
Zhang Y, Zhou Y, Li W, et al. Multiparameter affinity microchip for early sepsis diagnosis based on CD64 and CD69 expression and cell capture. Analytical Chemistry 2018; 90: 7204-7211.